Philadelphia, PA USA
Add to Favorites | Newsroom RSS | Share

Our News on Newswise

Principal Investigators at The Wistar Institute Have Secured Nearly $14 Million in Funding


Wistar scientists have received nearly $1
28-Sep-2016 11:00 AM EDT Add to Favorites

Anti-Tumor Immunity Identified with New Ovarian Cancer Treatment Strategy

New research from The Wistar Institute demonstrates how a drug already in clinical trials could be used to boost anti-tumor immunity and cause T-cells to target the cancer directly while minimizing side effects.
8-Sep-2016 4:05 PM EDT Add to Favorites

The Wistar Institute Names Ashani Weeraratna, Ph.D., the Ira Brind Associate Professor for Outstanding Scientific Leadership


Wistar is pleased to announce that Ashani Weeraratna, Ph.D., associate professor and program leader in the Tumor Microenvironment and Metastasis Program, has been named the Ira Brind Associate Professor.
9-Sep-2016 2:05 PM EDT Add to Favorites

Two Key Proteins Preserve Vital Genetic Information

New research from The Wistar Institute demonstrates how two key proteins mediate the organization of chromosomes and our genome, shedding light on one of the key genetic processes for every person. With this key basic information in hand, scientists...
19-Aug-2016 11:00 AM EDT Add to Favorites

Wistar Receives the Pennsylvania Dept. Of Labor & Industry Apprenticeship Grant to Further Explore Workforce Development Through Career Education


Wistar has been awarded a Nontraditional Apprenticeship Grant by the Pa. Dept. of Labor & Industry to explore implementing the Biomedical Technician Training Program for the Pa. region.
11-Aug-2016 10:00 AM EDT Add to Favorites

Low Oxygen, High Risk: How Tumors Adapt to Become More Aggressive


Wistar scientists have identified a novel mechanism that selectively operates in hypoxic tumors to enable tumor cells to thrive and continue to proliferate despite a low oxygen environment. Dario C. Altieri, M.D., Wistar’s President and CEO and...
4-Aug-2016 11:00 AM EDT Add to Favorites

Wistar Scientists Identify Marker for Myeloid-Derived Suppressor Cells


Wistar scientists have identified a marker that distinguishes PMN-MDSCs from neutrophils in the blood of patients with a variety of cancers.
3-Aug-2016 2:00 PM EDT Add to Favorites

T-Cells Can Be Directed to Treat a Variety of Ovarian Cancers

Scientists at The Wistar Institute have discovered a receptor-protein that is expressed on the surface of different types of ovarian tumor cells, including clear cell and mucinous ovarian tumors, two of the most aggressive subtypes of the disease....
28-Jul-2016 10:05 AM EDT Add to Favorites

Our YouTube Videos

Chat now!